Barry P Flannelly - Net Worth and Insider Trading
Barry P Flannelly Net Worth
The estimated net worth of Barry P Flannelly is at least $4 Million dollars as of 2023-05-31. Barry P Flannelly is the EVP & General Manager US of Incyte Corp and owns about 72,674 shares of Incyte Corp (INCY) stock worth over $4 Million. Details can be seen in Barry P Flannelly's Latest Holdings Summary section.
Transaction Summary of Barry P Flannelly
Barry P Flannelly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barry P Flannelly owns 2 companies in total, including Protara Therapeutics Inc (TARA) , and Incyte Corp (INCY) .
Click here to see the complete history of Barry P Flannelly’s form 4 insider trades.
Insider Ownership Summary of Barry P Flannelly
|Ticker||Comapny||Transaction Date||Type of Owner|
|TARA||Protara Therapeutics Inc||2020-07-23||director|
|INCY||Incyte Corp||2014-08-11||See Remarks|
Barry P Flannelly Latest Holdings Summary
Barry P Flannelly currently owns a total of 1 stock. Barry P Flannelly owns 72,674 shares of Incyte Corp (INCY) as of July 7, 2022, with a value of $4 Million.
Latest Holdings of Barry P Flannelly
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
Holding Weightings of Barry P Flannelly
Barry P Flannelly Form 4 Trading Tracker
According to the SEC Form 4 filings, Barry P Flannelly has made a total of 14 transactions in Incyte Corp (INCY) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Incyte Corp is the sale of 2,873 shares on July 7, 2022, which brought Barry P Flannelly around $228,059.
Insider Trading History of Barry P Flannelly
Barry P Flannelly Trading Performance
Barry P Flannelly Ownership Network
Ownership Network List of Barry P Flannelly
Ownership Network Relation of Barry P Flannelly
Barry P Flannelly Owned Company Details
What does Protara Therapeutics Inc do?
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Who are the key executives at Protara Therapeutics Inc?
Barry P Flannelly is the director of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include Chief Financial Officer Patrick Fabbio , VP & Controller Hannah Fry , and Chief Medical Officer Jathin Bandari .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Barry P Flannelly made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net purchase of 113,377 shares made by Opaleye Management Inc. , a net purchase of 30,000 shares made by Luke M Beshar , and a net purchase of 9,065 shares made by Jesse Shefferman .
In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 167,915 shares were bought by its insiders, resulting in a net purchase of 152,442 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
Barry P Flannelly Mailing Address
Above is the net worth, insider trading, and ownership report for Barry P Flannelly. You might contact Barry P Flannelly via mailing address: Route 141 And Henry Clay Road, Wilmington De 19880.